Erythrocyte glutathione transferase activity

A possible early biomarker for blood toxicity in uremic diabetic patients

Annalisa Noce, Raffaele Fabrini, Mariarita Dessì, Alessio Bocedi, Silvia Santini, Valentina Rovella, Anna Pastore, Manfredi Tesauro, Sergio Bernardini, Nicola Di Daniele, Giorgio Ricci

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Erythrocyte glutathione transferase (e-GST) displays increased activity in patients with renal damage and positive correlation with homocysteine (Hcy) in patients under maintenance hemodialysis. Here, we determined e-GST, Hcy, and erythrocyte catalase (e-CAT) in 328 patients affected by type 2 diabetes mellitus (T2DM), 61 diabetic non-nephropathic patients and 267 affected by diabetes and by chronic kidney disease (CKD) under conservative therapy subdivided into four stages according to K-DOQI lines. e-GST activity was significantly higher in all T2DM patients compared to the control group (7.90 ± 0.26 vs. 5.6 ± 0.4 U/gHb), and we observed an enhanced activity in all subgroups of CKD diabetic patients. No significant correlation or increase has been found for e-CAT in all patients tested. Mean Hcy in diabetic patients is higher than that in healthy subjects (33.42 ± 1.23 vs. 13.6 ± 0.8 μM), and Hcy increases in relation to the CKD stage. As expected, a significant correlation was found between e-GST and Hcy levels. These findings suggest that e-GST hyperactivity is not caused directly by diabetes but by its consequent renal damage. e-GST, as well as Hcy, may represent an early biomarker of renal failure.

Original languageEnglish
Pages (from-to)219-224
Number of pages6
JournalActa Diabetologica
Volume51
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Glutathione Transferase
Homocysteine
Erythrocytes
Biomarkers
Chronic Renal Insufficiency
Catalase
Type 2 Diabetes Mellitus
Kidney
Renal Insufficiency
Renal Dialysis
Healthy Volunteers
Maintenance
Control Groups

Keywords

  • Chronic kidney disease
  • Diabetes
  • Erythrocyte catalase
  • Erythrocyte glutathione transferase
  • Homocysteine

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Erythrocyte glutathione transferase activity : A possible early biomarker for blood toxicity in uremic diabetic patients. / Noce, Annalisa; Fabrini, Raffaele; Dessì, Mariarita; Bocedi, Alessio; Santini, Silvia; Rovella, Valentina; Pastore, Anna; Tesauro, Manfredi; Bernardini, Sergio; Di Daniele, Nicola; Ricci, Giorgio.

In: Acta Diabetologica, Vol. 51, No. 2, 2014, p. 219-224.

Research output: Contribution to journalArticle

Noce, A, Fabrini, R, Dessì, M, Bocedi, A, Santini, S, Rovella, V, Pastore, A, Tesauro, M, Bernardini, S, Di Daniele, N & Ricci, G 2014, 'Erythrocyte glutathione transferase activity: A possible early biomarker for blood toxicity in uremic diabetic patients', Acta Diabetologica, vol. 51, no. 2, pp. 219-224. https://doi.org/10.1007/s00592-013-0497-3
Noce, Annalisa ; Fabrini, Raffaele ; Dessì, Mariarita ; Bocedi, Alessio ; Santini, Silvia ; Rovella, Valentina ; Pastore, Anna ; Tesauro, Manfredi ; Bernardini, Sergio ; Di Daniele, Nicola ; Ricci, Giorgio. / Erythrocyte glutathione transferase activity : A possible early biomarker for blood toxicity in uremic diabetic patients. In: Acta Diabetologica. 2014 ; Vol. 51, No. 2. pp. 219-224.
@article{d5d6aeddd3a94c6a9c3870d219c467ab,
title = "Erythrocyte glutathione transferase activity: A possible early biomarker for blood toxicity in uremic diabetic patients",
abstract = "Erythrocyte glutathione transferase (e-GST) displays increased activity in patients with renal damage and positive correlation with homocysteine (Hcy) in patients under maintenance hemodialysis. Here, we determined e-GST, Hcy, and erythrocyte catalase (e-CAT) in 328 patients affected by type 2 diabetes mellitus (T2DM), 61 diabetic non-nephropathic patients and 267 affected by diabetes and by chronic kidney disease (CKD) under conservative therapy subdivided into four stages according to K-DOQI lines. e-GST activity was significantly higher in all T2DM patients compared to the control group (7.90 ± 0.26 vs. 5.6 ± 0.4 U/gHb), and we observed an enhanced activity in all subgroups of CKD diabetic patients. No significant correlation or increase has been found for e-CAT in all patients tested. Mean Hcy in diabetic patients is higher than that in healthy subjects (33.42 ± 1.23 vs. 13.6 ± 0.8 μM), and Hcy increases in relation to the CKD stage. As expected, a significant correlation was found between e-GST and Hcy levels. These findings suggest that e-GST hyperactivity is not caused directly by diabetes but by its consequent renal damage. e-GST, as well as Hcy, may represent an early biomarker of renal failure.",
keywords = "Chronic kidney disease, Diabetes, Erythrocyte catalase, Erythrocyte glutathione transferase, Homocysteine",
author = "Annalisa Noce and Raffaele Fabrini and Mariarita Dess{\`i} and Alessio Bocedi and Silvia Santini and Valentina Rovella and Anna Pastore and Manfredi Tesauro and Sergio Bernardini and {Di Daniele}, Nicola and Giorgio Ricci",
year = "2014",
doi = "10.1007/s00592-013-0497-3",
language = "English",
volume = "51",
pages = "219--224",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "2",

}

TY - JOUR

T1 - Erythrocyte glutathione transferase activity

T2 - A possible early biomarker for blood toxicity in uremic diabetic patients

AU - Noce, Annalisa

AU - Fabrini, Raffaele

AU - Dessì, Mariarita

AU - Bocedi, Alessio

AU - Santini, Silvia

AU - Rovella, Valentina

AU - Pastore, Anna

AU - Tesauro, Manfredi

AU - Bernardini, Sergio

AU - Di Daniele, Nicola

AU - Ricci, Giorgio

PY - 2014

Y1 - 2014

N2 - Erythrocyte glutathione transferase (e-GST) displays increased activity in patients with renal damage and positive correlation with homocysteine (Hcy) in patients under maintenance hemodialysis. Here, we determined e-GST, Hcy, and erythrocyte catalase (e-CAT) in 328 patients affected by type 2 diabetes mellitus (T2DM), 61 diabetic non-nephropathic patients and 267 affected by diabetes and by chronic kidney disease (CKD) under conservative therapy subdivided into four stages according to K-DOQI lines. e-GST activity was significantly higher in all T2DM patients compared to the control group (7.90 ± 0.26 vs. 5.6 ± 0.4 U/gHb), and we observed an enhanced activity in all subgroups of CKD diabetic patients. No significant correlation or increase has been found for e-CAT in all patients tested. Mean Hcy in diabetic patients is higher than that in healthy subjects (33.42 ± 1.23 vs. 13.6 ± 0.8 μM), and Hcy increases in relation to the CKD stage. As expected, a significant correlation was found between e-GST and Hcy levels. These findings suggest that e-GST hyperactivity is not caused directly by diabetes but by its consequent renal damage. e-GST, as well as Hcy, may represent an early biomarker of renal failure.

AB - Erythrocyte glutathione transferase (e-GST) displays increased activity in patients with renal damage and positive correlation with homocysteine (Hcy) in patients under maintenance hemodialysis. Here, we determined e-GST, Hcy, and erythrocyte catalase (e-CAT) in 328 patients affected by type 2 diabetes mellitus (T2DM), 61 diabetic non-nephropathic patients and 267 affected by diabetes and by chronic kidney disease (CKD) under conservative therapy subdivided into four stages according to K-DOQI lines. e-GST activity was significantly higher in all T2DM patients compared to the control group (7.90 ± 0.26 vs. 5.6 ± 0.4 U/gHb), and we observed an enhanced activity in all subgroups of CKD diabetic patients. No significant correlation or increase has been found for e-CAT in all patients tested. Mean Hcy in diabetic patients is higher than that in healthy subjects (33.42 ± 1.23 vs. 13.6 ± 0.8 μM), and Hcy increases in relation to the CKD stage. As expected, a significant correlation was found between e-GST and Hcy levels. These findings suggest that e-GST hyperactivity is not caused directly by diabetes but by its consequent renal damage. e-GST, as well as Hcy, may represent an early biomarker of renal failure.

KW - Chronic kidney disease

KW - Diabetes

KW - Erythrocyte catalase

KW - Erythrocyte glutathione transferase

KW - Homocysteine

UR - http://www.scopus.com/inward/record.url?scp=84898411889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898411889&partnerID=8YFLogxK

U2 - 10.1007/s00592-013-0497-3

DO - 10.1007/s00592-013-0497-3

M3 - Article

VL - 51

SP - 219

EP - 224

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 2

ER -